Share4Rare
rare diseases, patient data, Human Phenotype Ontology, HPO, EU Horizon 2020, Sant Joan de Déu, UPC, bioinformatics, people like me

| Status | Project concluded · Platform still active |
| Funding | EU Horizon 2020 · Agreement #780262 |
| Coordinator | Sant Joan de Déu Foundation, Barcelona |
| B2SLab role | Data science platform design, build, and maintenance |
| Duration | 2018 – 2022 (EU project) |
| Platform | share4rare.org |
B2SLab’s Role: the Data Science Engine
B2SLab was the data science and biostatistics partner within the consortium. Our contribution went far beyond analysis — we designed, built, and deployed the entire data science infrastructure that powers the platform’s intelligence layer.
The data pipeline
When a patient donates clinical information on Share4Rare, that data does not simply sit in a database. B2SLab built the pipeline that:
Standardises donated phenotypic data using the Human Phenotype Ontology (HPO) — a controlled vocabulary that allows clinical terms reported in plain language to be mapped to formal, interoperable medical concepts. This is essential in rare diseases, where patients and clinicians often use different words to describe the same finding.
Processes the harmonised data mathematically to extract meaningful patterns — identifying which patients share phenotypic profiles, clustering conditions by symptom overlap, and surfacing structure in data that would otherwise be invisible.
Feeds results back into the platform as actionable features. The most visible of these is “Personas Como Yo” (People Like Me) — a recommender system that connects patients with similar clinical profiles, letting someone with an undiagnosed condition or a rare syndrome find others who may share their journey.
The data processing approach was presented publicly by Prof. Alexandre Perera Lluna in the Share4Rare Webinar VI (How your data is processed in Share4Rare, 2019), one of a series of community-facing educational sessions on the platform’s workings.
The Platform Today
The EU project may have concluded, but Share4Rare keeps growing:

Platform scale (2026)
- 5,000+ patient and caregiver users
- 50+ countries represented
- Active research studies across multiple rare disease categories
- Ongoing open calls for academic research proposals
Active disease areas: - Neuromuscular disorders (incl. Duchenne MD) - Rare paediatric tumours - Undiagnosed conditions - Epidermolysis Bullosa - Phenylketonuria (PKU) - Rett syndrome - Rare cardiac, renal, and vascular diseases - Alpha-1 antitrypsin deficiency
The platform’s research programme remains open: academic centres and patient associations can submit study proposals. B2SLab continues to provide the data science infrastructure that makes these studies possible.
Consortium
The Share4Rare consortium brought together eight European partners:
| Partner | Country | Role |
|---|---|---|
| Sant Joan de Déu Foundation | Spain | Project coordinator; clinical leadership |
| Universitat Politècnica de Catalunya / B2SLab | Spain | Data science platform; biostatistics |
| Omada Interactiva | Spain | Technology development |
| World Duchenne Organization (UPPMD) | Netherlands | Patient organisation (neuromuscular) |
| Melanoma Patient Network Europe (MPNE) | Belgium | Patient organisation (rare tumours) |
| The Synergist | UK | Social innovation |
| Newcastle University | UK | Clinical expertise (neuromuscular) |
| Asserta | Spain | Socioeconomic impact |
Links
- Platform: share4rare.org
- Webinar VI — How your data is processed: share4rare.org/es/news/share4rare-webinar-vi-…
- EU project record: Horizon 2020 Agreement #780262
- B2SLab blog post (2018 kick-off): B2SLab Takes Part In Share4Rare
